ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1440

Significant Indicators Identified for Carotid Doppler Ultrasound Use in Axial Spondyloarthritis Patients Without Conventional Cardiovascular Risk Factors

Brona Dinneen1 and Finbar O'Shea2, 1St James's Hospital,, Dublin, Dublin, Ireland, 2St James's Hospital, Dublin, Dublin, Ireland

Meeting: ACR Convergence 2024

Keywords: Ankylosing spondylitis (AS), Cardiovascular, Carotid Artery Disease, practice guidelines, Spondyloarthropathies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: The EULAR  cardiovascular screening recommendations advocate for the use of carotid dopplers in patients with inflammatory joint diseases to detect subclinical atherosclerosis. Despite these guidelines, there is no clear consensus on which specific patients should undergo carotid doppler screening. This study aims to identify significant predictors that can help define criteria for performing carotid doppler ultrasound in axial spondyloarthritis patients without conventional cardiovascular risk factors.

Methods: 30 patients were recruited for this observational cross-sectional study. Patients aged  between 18-60 with a diagnosis of axial spondyloarthritis (axSpA) were evaluated for cardiovascular risk markers and carotid intima-media thickness (cIMT), defined as abnormal ( >0.8mm) and normal (< 0.8mm). Exclusion criteria included pregnancy, prior cardiovascular conditions, and other rheumatic diseases. Significant predictors of abnormal cIMT (p< 0.05) were identified through statistical analysis using Microsoft Excel

Results:  

Table 1 and 2 present the general characteristics of the study group, comparing patients with normal and abnormal cIMT. Statistically significant predictors of abnormal cIMT ( >0.8mm) include shorter disease duration (8.00 vs. 15.21 years, p=0.001), HLAB27 status (73% HLAB27+ vs 95 % HLAB27+, p=0.035), negative family history of ischemic heart disease (11% vs. 73% with positive family history, p=0.0017), higher diastolic blood pressure (83.55 vs. 78 mmHg, p=0.001), higher waist-hip ratio (0.95 vs. 0.88, p=0.001), higher ferritin levels (89.85 vs. 60.41 ng/mL, p=0.04), higher total cholesterol (4.91 vs. 4.44 mmol/L, p=0.04), higher LDL (3.00 vs. 2.61 mmol/L, p=0.05), and higher Total Cholesterol:HDL ratio (3.7 vs. 3.18, p=0.01)

Conclusion: These findings suggest that simple standard-of-care examinations can effectively identify axSpA patients, deemed to be at low risk for cardiovascular disease, for carotid doppler ultrasound screening. By utilizing predictors such as HLAB27 status, family history of ischemic heart disease, blood pressure, waist-hip ratio, ferritin levels, and cholesterol levels, healthcare providers can better stratify risk. Several factors traditionally associated with cardiovascular risk did not show significant differences between the groups with normal and abnormal cIMT. Disease activity scores, such as ASDAS-CRP and BASDAI, along with inflammatory markers like CRP and ESR, did not differ significantly, suggesting that active inflammation or disease severity might not directly correlate with subclinical atherosclerosis in this cohort.
This study can facilitate the development of appropriate utilization of carotid doppler ultrasound in detecting subclinical atherosclerosis, enhancing early cardiovascular disease detection and management in axSpA patients.

Supporting image 1

General characteristics 1

Supporting image 2

General characteristic 2


Disclosures: B. Dinneen: None; F. O'Shea: None.

To cite this abstract in AMA style:

Dinneen B, O'Shea F. Significant Indicators Identified for Carotid Doppler Ultrasound Use in Axial Spondyloarthritis Patients Without Conventional Cardiovascular Risk Factors [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/significant-indicators-identified-for-carotid-doppler-ultrasound-use-in-axial-spondyloarthritis-patients-without-conventional-cardiovascular-risk-factors/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/significant-indicators-identified-for-carotid-doppler-ultrasound-use-in-axial-spondyloarthritis-patients-without-conventional-cardiovascular-risk-factors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology